equol has been researched along with Local Neoplasm Recurrence in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Doihara, H; Hatono, M; Ikeda, H; Iwamoto, T; Kajiwara, Y; Kawada, K; Kochi, M; Shien, T; Suzawa, K; Suzuki, Y; Taira, N; Toyooka, S; Tsukioki, T; Yamamoto, H; Yamane, M | 1 |
| Anai, S; Chang, M; Hou, W; Pendleton, JM; Rosser, CJ; Shiverick, KT; Tan, WW | 1 |
1 trial(s) available for equol and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Phase II trial of isoflavone in prostate-specific antigen recurrent prostate cancer after previous local therapy.
Topics: Adenocarcinoma; Aged; Dietary Supplements; Equol; Genistein; Humans; Isoflavones; Male; Middle Aged; Neoplasm Recurrence, Local; Polymorphism, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Quality of Life; Receptors, Androgen | 2008 |
1 other study(ies) available for equol and Local Neoplasm Recurrence
| Article | Year |
|---|---|
Effect of isoflavones on breast cancer cell development and their impact on breast cancer treatments.
Topics: Breast Neoplasms; Equol; Humans; Isoflavones; Neoplasm Recurrence, Local; Tamoxifen; Tumor Cells, Cultured | 2021 |